Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2026)

Amphastar Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 8 years, most recently at $16.4 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 119.7% year-over-year to $16.4 million; the TTM value through Dec 2025 reached $90.3 million, down 28.35%, while the annual FY2025 figure was $90.3 million, 28.35% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $16.4 million at Amphastar Pharmaceuticals, down from $22.5 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $65.8 million in Q2 2024 and troughed at -$179000.0 in Q4 2023.
  • A 5-year average of $15.1 million and a median of $10.1 million in 2022 define the central range for Change in Acquisitions & Divestments.
  • Biggest five-year swings in Change in Acquisitions & Divestments: crashed 101.43% in 2023 and later skyrocketed 4281.01% in 2024.
  • Year by year, Change in Acquisitions & Divestments stood at $1.3 million in 2021, then skyrocketed by 827.6% to $12.5 million in 2022, then crashed by 101.43% to -$179000.0 in 2023, then skyrocketed by 4281.01% to $7.5 million in 2024, then soared by 119.7% to $16.4 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for AMPH at $16.4 million in Q4 2025, $22.5 million in Q3 2025, and $23.0 million in Q2 2025.